Overall Technical outlook

Price Summary

With a 3.06% climb, Glenmark Pharmaceuticals Limited enjoyed a robust day in the stock market.
On 2025-09-05, Glenmark Pharmaceuticals Limited's stock began at 1990.9, peaked at 2055.2, declined to 1990.9, and ended the day 3.06% up at 2051.9, with 976956 shares traded.
Over the course of 52 weeks, the stock peaked at 2226.7 and hit a low of 1278.95.
The future price of GLENMARK is projected to range from 1500.0 to 2934.0, with an average expected price of 2124.182, according to 11 analysts.

Technicals

Support and Resistance: The price of 2051.9 is supported at 1940.9 and capped by resistance at 2144.2. These levels mark key points for Glenmark Pharmaceuticals Limited where the price could find stability, with 1940.9 as a floor and 2144.2 as a ceiling.
GLENMARK supportResistance 6e438c
Support/Resistance for GLENMARK


Aroon: A strong bullish trend is currently being indicated by the AROON. The Aroon Up has moved higher, and the Aroon Oscillator has reversed, signaling a shift to an upward trend. This suggests that the market may be entering a period of increased bullish activity, with investors likely to see further price increases in the price of Glenmark Pharmaceuticals Limited in the near future.
GLENMARK aroon 6e438c
Aroon chart for Glenmark Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
GLENMARK bbands 6e438c
Bolinger Bands chart for Glenmark Pharmaceuticals Limited


Parabolic SAR: The PSAR continues to be bullish for GLENMARK, setting a strong support level that could sustain the ongoing upward trend. This level of support indicates that the market is likely to continue its positive trajectory, offering a base for continued bullish movement.
GLENMARK psar 6e438c
Parabolic Stop and Reverse chart for Glenmark Pharmaceuticals Limited


Stochastic: The STOCHASTIC is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
GLENMARK stoch 6e438c
Stochastic chart for Glenmark Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral stance, with no definitive indication of an upward or downward trend for GLENMARK. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
GLENMARK trippleSMA 6e438c
Tripple SMA chart for Glenmark Pharmaceuticals Limited


A company's technical data, including stock price and trading volume, can provide valuable insights when considered alongside its fundamentals. These include financial performance, market share, and growth strategy, as well as broader industry dynamics. Examining these factors helps investors or analysts make more informed decisions, as the company's fundamentals offer context for understanding how and why certain technical patterns may emerge in the market.